Literature DB >> 7574861

A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension.

I Moncica1, P I Oh, I ul Qamar, D Scolnik, G S Arbus, D Hebert, J W Balfe, G Koren.   

Abstract

In a crossover design, control of blood pressure by extended release felodipine was compared with control by prolonged action nifedipine in 21 children with renal hypertension. Compliance with once daily felodipine was higher than with nifedipine, at 95.6 (SEM 2.7)% v 78.9 (6.0)% (p = 0.02). Mean diastolic blood pressure was lower during the day with felodipine than with nifedipine, at 77.6 (2.4) v 84.4 (2.8) mm Hg (p = 0.05). Similarly, blood pressure load (the percentage of the day during which the child had blood pressure exceeding the upper limits of normal for age) was lower for felodipine than for nifedipine: 43.5 (5.5)% v 61.3 (6.3)%. There was an opposite trend during the night, though this did not reach statistical significance. These data suggest that once a day felodipine is effective in children with hypertension. This may be because of improved compliance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574861      PMCID: PMC1511218          DOI: 10.1136/adc.73.2.154

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

Review 1.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

2.  Nifedipine in the treatment of systemic hypertension.

Authors:  W H Frishman; S Charlap
Journal:  Arch Intern Med       Date:  1984-12

3.  Medication compliance.

Authors:  J T Shope
Journal:  Pediatr Clin North Am       Date:  1981-02       Impact factor: 3.278

Review 4.  A review of the antihypertensive effects of felodipine alone or in combination.

Authors:  T O Morgan
Journal:  J Cardiovasc Pharmacol       Date:  1990       Impact factor: 3.105

Review 5.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

Review 6.  Investigation and management of hypertension in children. A personal perspective.

Authors:  M J Dillon
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

  6 in total
  5 in total

Review 1.  Pharmacologic treatment of chronic pediatric hypertension.

Authors:  Renee F Robinson; Milap C Nahata; Donald L Batisky; John D Mahan
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

2.  Clinical trial of extended-release felodipine in pediatric essential hypertension.

Authors:  Howard Trachtman; Rachel Frank; John D Mahan; Ronald Portman; Irene Restaino; Tej K Matoo; Conrad Tou; Michael Klibaner
Journal:  Pediatr Nephrol       Date:  2003-04-17       Impact factor: 3.714

Review 3.  A review of calcium channel antagonists in the treatment of pediatric hypertension.

Authors:  Shobha Sahney
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 4.  Current issues in pediatric medication adherence.

Authors:  Doreen Matsui
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 5.  Antihypertensive agents: a long way to safe drug prescribing in children.

Authors:  Nida Siddiqi; Ibrahim F Shatat
Journal:  Pediatr Nephrol       Date:  2019-11-01       Impact factor: 3.651

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.